Global Hospital-acquired Disease Testing Market 2015-2019 - Rising Prevalence of HAIs / Lack of Healthcare Infrastructure / Technological Advancements

News provided by

Research and Markets

20 Oct, 2015, 06:10 ET

DUBLIN, Oct. 19, 2015 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/nzvw7k/global) has announced the addition of the "Global Hospital-acquired Disease Testing Market 2015-2019" report to their offering.

The global hospital-acquired disease testing market to grow at a CAGR of 19.44% over the period 2014-2019.

The report, Global Hospital-acquired Disease Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global hospital-acquired disease testing market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

The technological advance in the molecular diagnostic field is one of the key trends in the global hospital acquired disease testing market. The continuous innovation in increasing the performance and speed of molecular diagnostics is an integral part of the infectious diagnostic testing field.

According to the report, the rising prevalence of hospital acquired infections has a significant impact on both developed and developing countries and remains one of the major drivers of the growth of the market.

Further, the report states that lack of healthcare infrastructure, training, and awareness of how hospital acquired infections spread remain major hindrances to the growth of the market. Early diagnosis and regular monitoring of patients with these diseases is essential to identify, treat, and control their spread. This has generated substantial demand for hospital acquired disease testing products including instruments, testing kits, and reagents.

To calculate the market size, we consider revenue generated from the sales of testing products used in the following hospital-acquired disease infections:

  • SSIs
  • UTIs
  • Bbloodstream infections
  • Pneumococcal infections
  • MRSA
  • Others

Key Vendors

  • Abbott Laboratories
  • Becton and Dickenson
  • bioMerieux
  • Roche Diagnostics

Other Prominent Vendors

  • Akers Biosciences
  • Alere
  • Beckman Coulter/Danaher
  • Cantel Medical
  • Cepheid
  • Diatherix Laboratories
  • Eiken Chemical
  • Enzo Biochem
  • Fujirebio/Innogenetics
  • Gen-Probe
  • Humor Diagnostica
  • Life Technologies
  • Meridian Bioscience
  • Nordion
  • QIAGEN

For more information visit http://www.researchandmarkets.com/research/nzvw7k/global

Media Contact:

Laura Wood, +353-1-481-1716, [email protected]

SOURCE Research and Markets

Related Links

http://www.researchandmarkets.com

Also from this source

Global Downstream Processing Market Research Report 2023-2030: Single-Use Technologies Set to Transform Downstream Processing for Small-Volume, High-Potency Drugs

Global Sandwich Panels Market Report 2023-2030: Competition Heats Up in the Sandwich Panels Market Amidst Construction Industry Expansion

Explore

More news releases in similar topics

PRN Top Stories Newsletters

Sign up to get PRN’s top stories and curated news delivered to your inbox weekly!

Thank you for subscribing!

By signing up you agree to receive content from us.
Our newsletters contain tracking pixels to help us deliver unique content based on each subscriber's engagement and interests. For more information on how we will use your data to ensure we send you relevant content please visit our PRN Consumer Newsletter Privacy Notice. You can withdraw your consent at any time in the footer of every email you'll receive. Mit Ihrer Anmeldung erklären Sie sich damit einverstanden, Inhalte von uns zu erhalten.
Unsere Newsletter enthalten Zählpixel, die die Lieferung einzigartiger Inhalte in Bezug auf das Abonnement und die Interessen der einzelnen Abonnenten ermöglichen. Weitere Informationen über die Verwendung Ihrer Daten im Hinblick auf die Zusendung von relevanten Inhalten, finden Sie in unserer PRN Consumer Newsletter Privacy Notice. Ihre Zustimmung können Sie jederzeit in der Fußzeile jeder erhaltenen E-Mail widerrufen. En vous inscrivant à la newsletter, vous consentez à la réception de contenus de notre part.
Notre newsletter contient des pixels espions nous permettant la fourniture à chaque abonné, d’un contenu unique en lien avec ses souscriptions et intérêts. Pour de plus amples informations sur l’utilisation faite de vos données en vue de l’envoi des contenus concernés, nous vous invitons à consulter la politique de confidentialité disponible à partir du lien suivant PRN Consumer Newsletter Privacy Notice. Vous pouvez à tout moment revenir sur votre consentement par le biais des informations situées au bas de chaque e-mail reçu. Регистрирайки се, Вие се съгласявате да получавате информационно съдържание от нас. Нашите бюлетини съдържат проследяващи пиксели, които ни помагат да предоставяме уникално съдържание въз основа на ангажираността и интересите на всеки абонат. За повече информация относно начина, по който ще използваме Вашите данни, за да гарантираме, че Ви изпращаме подходящо съдържание, моля, направете справка с нашето Уведомление за поверителност на потребителския бюлетин на PRN. Можете да оттеглите съгласието си по всяко време в долния колонтитул на всеки от имейлите, които ще получите.